ReviewFrontiers in cell and developmental biology2026

The 2025 paradigm shift in urothelial carcinoma pharmacotherapy: from chemotherapy to ADCs and ICIs.

Yong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.